BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8916979)

  • 1. The effects of oestrogen deficiency on the skeleton and its prevention.
    Fogelman I
    Br J Obstet Gynaecol; 1996 Oct; 103 Suppl 14():5-9. PubMed ID: 8916979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoporosis prevention with sex hormone replacement therapy.
    Rozenberg S; Vandromme J; Kroll M; Pastijn A; Degueldre M
    Int J Fertil Menopausal Stud; 1994; 39(5):262-71. PubMed ID: 7820159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogens in prevention and treatment of osteoporosis.
    Lindsay R
    Schweiz Med Wochenschr; 1989 Dec; 119(50):1806-10. PubMed ID: 2532784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are oestrogen deficiency and hormone replacement a distraction to the field of osteoporosis?
    Kanis JA
    Osteoporos Int; 1998; 8 Suppl 1():S51-6. PubMed ID: 9682799
    [No Abstract]   [Full Text] [Related]  

  • 5. Osteoporosis: new hope for the future.
    Masi L; Bilezikian JP
    Int J Fertil Womens Med; 1997; 42(4):245-54. PubMed ID: 9309458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmenopausal osteoporosis treatment guidelines.
    Sambrook P; O'Neill S; Diamond T; Flicker L; MacLennan A
    Aust Fam Physician; 2000 Aug; 29(8):751-3, 756-8. PubMed ID: 10958021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Selective estrogen receptor modulators (SERM): new substances for hormone replacement therapy].
    Burckhardt P
    Schweiz Med Wochenschr; 1999 Dec; 129(49):1926-30. PubMed ID: 10635085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates.
    Confavreux CB; Fontana A; Guastalla JP; Munoz F; Brun J; Delmas PD
    Bone; 2007 Sep; 41(3):346-52. PubMed ID: 17618847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the preventive role of estro-progestogens and non-hormonal therapies in postmenopausal osteoporosis].
    Reginster JY
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(7):677-83. PubMed ID: 8991900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sex hormones and osteoporosis: a physiological perspective for prevention and therapy].
    da Silva JA; Porto A
    Acta Med Port; 1997 Oct; 10(10):689-95. PubMed ID: 9477594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogens as first-choice therapy for osteoporosis prevention and treatment in women under 60.
    Studd J
    Climacteric; 2009 Jun; 12(3):206-9. PubMed ID: 19437196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Osteoporosis treatment by gynecologist].
    Mizunuma H
    Nihon Rinsho; 2003 Feb; 61(2):268-73. PubMed ID: 12638220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diphosphonates: and alternative to estrogen therapy in postmenopausal osteoporosis. Experience with alendronate].
    Buffo L; Rossini M; Buoncristiano A; Girardello S; Zamberlan N; Diani F; Adami S
    Minerva Ginecol; 1996 Jun; 48(6):263-72. PubMed ID: 8927288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of action of antiresorptive therapies of postmenopausal osteoporosis.
    Stepan JJ; Alenfeld F; Boivin G; Feyen JH; Lakatos P
    Endocr Regul; 2003 Dec; 37(4):225-38. PubMed ID: 15106819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of postmenopausal osteoporosis: position statement of the North American Menopause Society.
    North American Menopause Society.
    Menopause; 2002; 9(2):84-101. PubMed ID: 11875327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group.
    Reid DM; Doughty J; Eastell R; Heys SD; Howell A; McCloskey EV; Powles T; Selby P; Coleman RE
    Cancer Treat Rev; 2008; 34 Suppl 1():S3-18. PubMed ID: 18515009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oral osteoporosis: a review and its dental implications].
    Inagaki K; Kurosu Y; Sakano M; Yamamoto G; Kikuchi T; Noguchi T; Yano H; Izawa H; Hachiya Y
    Clin Calcium; 2007 Feb; 17(2):157-63. PubMed ID: 17272871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diphosphonates--pharmacology and clinical use].
    Aaseth J; Syversen U; Førre O
    Tidsskr Nor Laegeforen; 1998 Mar; 118(7):1064-6. PubMed ID: 9531831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drugs for prevention and treatment of postmenopausal osteoporosis.
    Treat Guidel Med Lett; 2005 Oct; 3(38):69-74. PubMed ID: 16177651
    [No Abstract]   [Full Text] [Related]  

  • 20. Postmenopausal osteoporosis and hormone replacement therapy.
    Gambacciani M; Vacca F
    Minerva Med; 2004 Dec; 95(6):507-20. PubMed ID: 15785435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.